In the same study, analysis of infiltrating γδ T cells from non-tumor areas and tumors from CRC patients showed an enriched gene signature of some genes such as CD9 and LGALS3 that were described as associated with murine IL-17-producing γδ T cells [131] but no upregulation of IL-17A in the infiltrating T cells [130]. The gene discussed is IL17A; the disease is neoplasm.